Viral infection or TLR3 engagement causes activation of the transcription factors IRF-3 and NF-jB, which collaborate to induce transcription of type I IFN genes. IKKe and TBK1 are two IKK-related kinases critically involved in virus-and TLR3-triggered activation of IRF-3. We identified a protein termed SIKE (for Suppressor of IKKe) that interacts with IKKe and TBK1. SIKE is associated with TBK1 under physiological condition and dissociated from TBK1 upon viral infection or TLR3 stimulation. Overexpression of SIKE disrupted the interactions of IKKe or TBK1 with TRIF, RIG-I and IRF-3, components in virus-and TLR3-triggered IRF-3 activation pathways, but did not disrupt the interactions of TRIF with TRAF6 and RIP, components in TLR3-triggered NF-jB activation pathway. Consistently, overexpression of SIKE inhibited virus-and TLR3-triggered interferon-stimulated response elements (ISRE) but not NF-jB activation. Knockdown of SIKE potentiated virus-and TLR3-triggered ISRE but not NF-jB activation. Moreover, overexpression of SIKE inhibited IKKe-and TBK1-mediated antiviral response. These findings suggest that SIKE is a physiological suppressor of IKKe and TBK1 and plays an inhibitory role in virus-and TLR3-triggered IRF-3 but not NF-jB activation pathways.
Introduction
Viral infection results in induction of type I interferons (IFNs), including IFN-b and IFN-a family cytokines, which are critical mediators of antiviral responses (Durbin et al, 2000; Levy and Garcia-Sastre, 2001 ; Levy and Marie, 2004; Hengel et al, 2005) . Transcriptional induction of type I IFN genes requires the coordinate activation of multiple transcription factors and their cooperative assembly into transcriptional enhancer complexes in vivo. For example, the enhancer of the IFN-b gene contains a kB site recognized by NF-kB, a site for ATF-2/c-Jun and two IFN-stimulated response elements (ISREs) recognized by phosphorylated IRF-3 and/ or IRF-7 Wathelet et al, 1998) . It has been shown that transcriptional activation of the IFN-b gene requires coordinate and cooperative assembly of an enhanceosome that contains all of these transcription factors Wathelet et al, 1998) .
At least two distinct pathways for the activation of the innate antiviral responses by viral infection have been proposed (Levy and Garcia-Sastre, 2001; tenOever et al, 2002; Levy and Marie, 2004) . First, viruses enter cells by membrane fusion at the plasma membrane or through an endocytic process, leading to the release of viral nucleocapsids (or ribonucleoproteins) into the cytoplasm. The viral dsRNA, accumulated during replication of the viral genome, triggers signaling cascades that lead to the activation of IRF-3 and NF-kB and subsequent production of type I IFNs (Levy and Garcia-Sastre, 2001; tenOever et al, 2002) . Second, viral dsRNA, released upon lysis of infected cells, binds to TLR3 and triggers signaling pathways leading to IRF-3 and NF-kB activation (Alexopoulou et al, 2001; Yamamoto et al, 2002 Yamamoto et al, , 2003 Hoebe et al, 2003; Oshiumi et al, 2003; Han et al, 2004) . It has been proposed that TLR3 is important for systemic responses to viral infection but is not required for the initial, cell-autonomous recognition of viral infection that induces the first wave of type I IFN production (Honda et al, 2003; Levy and Marie, 2004; Yoneyama et al, 2004) .
The molecular components involved in virus-triggered TLR3-independent activation of IRF-3 and NF-kB have begun to emerge. It has been shown that two serine/threonine kinases, TBK1 (also known as NAK or T2K) and IKKe (also known as IKKi), phosphorylate IRF-3 and are involved in virus-triggered induction of type I IFNs in various cell types (Fitzgerald et al, 2003; Sharma et al, 2003; Hemmi et al, 2004; McWhirter et al, 2004; Perry et al, 2004) . More recently, a CARD module-containing RNA helicase protein, RIG-I, has been identified as a sensor of cytoplasmic viral dsRNA (Levy and Marie, 2004; Yoneyama et al, 2004) . Knockdown or knockout of RIG-I inhibits IFN-b production in response to Newcastle disease virus in different cell types, suggesting that RIG-I is required for virus-triggered signaling (Yoneyama et al, 2004; Kata et al, 2005) . It has been further shown that RIG-I-mediated signaling is independent of TLR3 (Yoneyama et al, 2004; Kata et al, 2005) .
In addition to virus-triggered TLR3-independent signaling pathways, TBK1 and IKKe are also involved in TLR3-mediated IRF-3 activation. It has been shown that TRIF, a TIR domain-containing adapter protein, is associated with TLR3 (Yamamoto et al, 2002 Hoebe et al, 2003; Oshiumi et al, 2003) . TRIF mediates IRF-3 and NF-kB activation through two distinct pathways. TRIF interacts with TBK1 and/or IKKe, which phosphorylate IRF-3. TRIF interacts with TRAF6 and RIP, which activate NF-kB through TAK1 and IKK (Hoebe et al, 2003; Sato et al, 2003; Han et al, 2004; Jiang et al, 2004; Meylan et al, 2004) .
Since IKKe and TBK1 are critically involved in virustriggered TLR3-dependent and -independent type I IFN signaling, we investigated whether these kinases are regulated by additional proteins. In this report, we performed yeast two-hybrid screens for potential IKKe-interacting proteins. This effort identified a protein designated as SIKE (for Suppressor of IKKe). Our findings suggest that SIKE is a physiological inhibitor of IKKe and TBK1 and plays an inhibitory role in virus-and TLR3-triggered IRF-3 but not NF-kB activation pathways.
Results

Identification of SIKE as an IKKe-and TBK1-interacting protein
To identify IKKe-interacting proteins, we used the yeast twohybrid system to screen a human B-cell cDNA library with full-length IKKe as bait. We screened a total of B8 Â10 6 independent clones and obtained 123 b-galactosidase positive clones. Four of these clones encoded an uncharacterized protein of 207 amino acids (aa) that was designed as SIKE. Blast searches of the GenBank databases indicated that SIKE is an evolutionarily conserved protein whose orthologs could be found from Xenopus to human (data not shown). An alignment of human and mouse SIKE aa sequences is shown in Figure 1A . Blast searches of the GenBank databases also indicated that SIKE belongs to an uncharacterized protein family, which includes several uncharacterized proteins, such as FGF receptor 1 oncogene partner 2, hematopoietic stem/progenitor cells 123 (HSPC123), HSCP123-like protein and two invertebrate proteins, Schistosoma mansoni circulating cathodic antigen and Drosophila unknown protein CG10158-PA.
Northern blot analysis indicated that human SIKE is ubiquitously expressed as a B5.5 kDa band in all examined tissues, including brain, heart, skeletal muscle, colon, thymus, spleen, kidney, liver, small intestine, placenta, lung and leukocytes ( Figure 1B) . Consistently, blast searches of the GenBank databases identified a human SIKE mRNA sequence of B5.5 kb with an open reading frame of 207 aa.
To determine whether SIKE is expressed in mammalian cells at the protein level, we raised mouse polyclonal antiserum against recombinant human SIKE. Western blot analysis indicated that SIKE was expressed as a B26 kDa protein in all examined cells, including Bjab, HeLa and 293 cells ( Figure 1C ). The size of endogenous SIKE was slightly smaller than overexpressed HA-tagged SIKE, suggesting that the identified SIKE cDNA encodes a full-length protein.
Immunofluorescent staining experiments indicated that SIKE is a cytoplasmic protein ( Figure 1D ). 
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hSIKE mSIKE 43 84 43 84 Figure 2A ). In these experiments, SIKE also interacted with TBK1 but not RIP (Figure 2A ), a kinase that is involved in TNF receptor and TLR3-induced NF-kB activation (Hsu et al, 1996; Meylan et al, 2004 P r e α S I K E P r e α S I K E P r e α S I K E P r e α S I K E -TBK1 Previously, it has been demonstrated that TBK1 is constitutively expressed in most cell types, while IKKe is undetectable under physiological conditions but inducible in lymphoid and other cell types (Pomerantz and Baltimore, 1999; Shimada et al, 1999; Peters et al, 2000) . Therefore, we examined whether SIKE is associated with TBK1 in untransfected cells. In co-immunoprecipitation experiments, endogenous SIKE interacted with endogenous TBK1 under physiological condition. This interaction was significantly decreased following virus infection or poly(I:C) treatment of TLR3-expressing 293 cells ( Figure 2B ). These data suggest that SIKE is constitutively associated with TBK1 under physiological condition, but dissociated from TBK1 upon virus infection or TLR3 activation.
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Since SIKE interacts with IKKe and TBK1, we performed structural analysis to determine whether they are structurally related to each other. Using the paircoil program, we found that SIKE contains two coiled-coil motifs at aa72-102 and aa163-197, respectively ( Figure 2C ). Interestingly, IKKe and TBK1 also contain two potential coiled-coil motifs at their C-terminuses ( Figure 2C ). Since coiled-coil motifs mediate homophilic multimerization, we determined whether SIKE could dimerize or oligomerize. In co-immunoprecipitation experiments, Flag-tagged SIKE could interact with HA-tagged SIKE ( Figure 2D ), suggesting that SIKE could form homodimmers or -oligomers.
We also made series of mutants of SIKE, IKKe and TBK1 and performed domain mapping experiments. We found that SIKE interacted with IKKe and TBK1 through their respective coiled-coil domains ( Figure 2D ).
To further characterize the association of SIKE with TBK1, we examined the biochemical nature of SIKE and TBK1 in untransfected cells. In these experiments, 293-TLR3 cells were treated with poly(I:C) for 10 min or left untreated, or 293 cells were infected with vesicular stomatitis virus (VSV) for 4 h or left uninfected before lysis. Cell lysates were separated by size-exclusion chromatography and individual fractions were analyzed by Western blots with antibodies against SIKE and TBK1, respectively. As shown in Figure 2E , SIKE and TBK1 exist in overlapping fractions that eluted in the 158-670 kDa range in uninfected cells. However, following poly(I:C) treatment or VSV infection, a significant part of SIKE was shifted to fractions peaking at about 25 and 44 kDa. Based on these data, we propose that SIKE is associated with TBK1, as well as unidentified proteins, as complexes of 158-670 kDa under physiological conditions. Upon poly(I:C) stimulation or viral infection, SIKE is dissociated from the TBK1-containing complexes to become free monomer (in 25 kDa fraction) or dimer (in 44 kDa fraction) ( Figure 2E ).
In the size-exclusion chromatography experiments, the molecular weights of TBK1-containing complexes were not decreased following virus infection or poly(I:C) treatment. It is possible that the molecular weight of dissociated SIKE is too small to have apparent effect on the molecular weights of TBK1-containing complexes. Alternatively, virus infection or poly(I:C) treatment may cause both dissociation of SIKE from the TBK1-containing complexes and recruitment of other proteins to the TBK1-containing complexes.
SIKE inhibits IKKe-and TBK1-mediated activation of ISRE and the IFN-b promoter
Overexpression of IKKe and TBK1 activates both ISRE and NF-kB (Pomerantz and Baltimore, 1999; Peters et al, 2000; Fitzgerald et al, 2003; Han et al, 2004) . Since SIKE interacts with IKKe and TBK1, we determined the effects of SIKE on IKKe-and TBK1-mediated signaling. In reporter gene assays, SIKE inhibited both IKKe-and TBK1-mediated activation of ISRE and the IFN-b promoter ( Figure 3A ). In similar experiments, SIKE did not inhibit IKKe-and TBK1-mediated NF-kB activation ( Figure 3A ). These results suggest that SIKE specifically inhibits IKKe-and TBK1-mediated IRF-3 pathways.
SIKE inhibits TLR3-mediated activation of ISRE and the IFN-b promoter
Since IKKe and TBK1 are critically involved in TLR3-triggered ISRE but not NF-kB activation pathways (Fitzgerald et al, 2003; Sharma et al, 2003; Hemmi et al, 2004; McWhirter et al, 2004; Perry et al, 2004) , we determined the effects of SIKE on these pathways. TRIF is a signaling component upstream of IKKe and TBK1 in TLR3-mediated signaling. In reporter gene assays, SIKE inhibited TRIF-mediated activation of ISRE and the IFN-b promoter ( Figure 3B ), but had no effect on TRIFmediated NF-kB activation ( Figure 3B ). In a poly(I:C)-responsive 293 cell line that stably expresses TLR3, SIKE inhibited poly(I:C)-induced activation of ISRE and the IFN-b promoter but not NF-kB ( Figure 3C ). In similar experiments, SIKE did not inhibit IRF3-mediated activation of ISRE and the IFN-b promoter (data not shown). These data suggest that SIKE specifically inhibits TLR3-mediated ISRE but not NF-kB activation pathways at TBK1 and/or IKKe level.
SIKE disrupts the interactions of IKKe or TBK1 with TRIF and IRF-3
One of the simplest explanations for the inhibitory role of SIKE on TLR3-mediated ISRE activation is that SIKE sequesters IKKe and/or TBK1 in an inactive complex and blocks their interactions with TRIF and/or IRF-3, two signaling components that are associated with IKKe and TBK1 in the TLR3-mediated ISRE activation pathway. To test this, we performed transient transfection and co-immunoprecipitation experiments. In these experiments, either IKKe or TBK1 interacted with TRIF and IRF-3 as expected. The interactions were completely disrupted with the addition of SIKE ( Figure  4A and B) . In similar experiments, SIKE did not disrupt the interactions of TRIF with TRAF6 and RIP, two components that are involved in TLR3-mediated NF-kB activation pathway ( Figure 4C ). Since SIKE did not interact with TRIF and IRF-3 in co-immunoprecipitation experiments (data not shown), these results suggest that SIKE specifically blocks the interactions of IKKe or TBK1 with TRIF or IRF-3 by its association with IKKe or TBK1.
SIKE inhibits virus-triggered TLR3-independent activation of ISRE and the IFN-b promoter
In addition to TLR3-mediated ISRE activation, IKKe and TBK1 are also involved in virus-triggered TLR3-independent activation of ISRE and the IFN-b promoter. Recent studies have indicated that RIG-I is a sensor of viral dsRNA in the cytoplasm and is critically involved in virus-triggered TLR3-indepenent signaling ( Rel. lucif. act.
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Rel. lucif. act. (Yoneyama et al, 2004) . Therefore, we examined the effects of SIKE on virus-induced and RIG-I-mediated TLR3-independent signaling. The parent 293 cells do not express TLR3 and are not responsive to poly(I:C) (Yoneyama et al, 2004 and data not shown). In these cells, SIKE inhibited VSV-induced and RIG-I-mediated activation of ISRE and the IFN-b promoter ( Figure 5A and B) . In similar experiments, SIKE did not inhibit VSV-induced and RIG-I-mediated activation of NF-kB ( Figure 5C ).
SIKE blocks the interaction of IKKe and TBK1 with RIG-I
It has been demonstrated that both RIG-I and IKKe or TBK1 are involved in virus-triggered TLR3-independent signaling ) were transfected with the indicated luciferase reporter plasmid (0.1 mg), an empty control vector or an expression plasmid for RIG-I (1 mg) as indicated, and an empty control vector (empty bars) or an expression plasmid for SIKE (filled bars). At 14 h after transfection, cells were infected with VSV or left infected for 18 h before luciferase assays were performed. Levy and Marie, 2004; Perry et al, 2004; tenOever et al, 2004) . However, the relationship between RIG-I and IKKe or TBK1 has not been revealed. We found that RIG-I could interact with IKKe and TBK1 in co-immunoprecipitation experiments ( Figure 6A and B) . The CARD modules but not the helicase domain of RIG-I is responsible for its interaction with IKKe and TBK1 ( Figure 6A and B) . In these experiments, the interactions of IKKe and TBK1 with RIG-I and its CARD modules were completely disrupted by the addition of SIKE ( Figure 6A and B) .
Knockdown of SIKE expression potentiates poly(I:C)-and VSV-induced activation of ISRE and the IFN-b promoter
To further determine whether SIKE is involved in the regulation of the ISRE activation pathways under physiological conditions, we constructed five human SIKE RNAi plasmids. One of these RNAi plasmids (#4) could significantly inhibit the expression of transfected and endogenous SIKE in 293 cells as suggested by Western blot analysis ( Figure 7A ). In reporter gene assays, this SIKE RNAi plasmid potentiated poly(I:C)-and VSV-triggered activation of ISRE and the IFN-b promoter but not NF-kB ( Figure 7B -G). These data suggest that SIKE is a physiological inhibitor of TLR3-and virustriggered ISRE but not NF-kB activation pathways.
Since SIKE inhibits TLR3-and virus-triggered ISRE activation, we further examined whether SIKE inhibits TLR3-mediated and virus-triggered expression of endogenous IFN-b and Rantes. In reverse-transcription polymerase chain reaction (RT-PCR) experiments, we found that SIKE RNAi potentiated basal as well as poly(I:C)-and virus-triggered expression of endogenous IFN-b and Rantes mRNA ( Figure 7H and I). These data suggest that SIKE is a physiological inhibitor of TLR3-mediated and virus-triggered gene expression.
SIKE inhibits IKKe-and TBK1-mediated antiviral response
IKKe and TBK1 have been demonstrated to be required for establishing the antiviral state and this activity is IRF3-dependent. Since SIKE could inhibit IKKe-and TBK1-mediated activation of ISRE and the IFN-b promoter, we determined whether SIKE has effects on IKKe-and TBKmediated antiviral response. We transfected 293 cells with IKKe/TBK1, together with a control plasmid or a SIKE expression or RNAi plasmid. The transfected cells were infected with VSV and replicated viruses released into the medium were quantitated by standard plaque assays. The results indicated that VSV production in the presence of IKKe/ TBK1 decreased by B4 logs to 10 4 plaque-forming units (PFU)/ml at 12 h postinfection (Figure 8) , which is consistent with the data reported previously (Sharma et al, 2003) . Overexpression of SIKE restored the VSV production to more than 10 6 PFU/ml ( Figure 8A ), while SIKE RNAi potentiated IKKe-and TBK1-mediated inhibition of VSV production ( Figure 8B ). These data indicate that SIKE is a physiological inhibitor of IKKe-and TBK1-mediated antiviral response. 
Discussion
The immune system has evolved distinct virus recognition strategies. Viruses can enter cells by membrane fusion or through endocytosis. The viral dsRNA accumulated during replication of the viral genome is detected by the RNA helicase protein RIG-I or MDA5 in the cytoplasm (Andrejeva et al, 2004; Yoneyama et al, 2004) . During late stage of infection, viral dsRNA is released upon lysis of infected cells and recognized by TLR3 (Alexopoulou et al, 2001; Levy and Marie, 2004) . These distinct virus recognition strategies trigger signaling pathways that converge on activation of the transcription factors NF-kB and IRF-3, leading to transcription of the antiviral type I IFNs. In these converged pathways, two noncanonical IKK family members, IKKe and TBK1, phosphorylate IRF-3 and are critically involved in virus-triggered TLR3-independent and TLR3-mediated induction of type I IFNs (Fitzgerald et al, 2003; Hoebe et al, 2003; Oshiumi et al, 2003; Sharma et al, 2003; Although it is clear that IKKe and TBK1 play essential roles in antiviral responses in various cell types, how their activities are regulated is unknown. To get insight into this, we searched for additional IKKe-interacting proteins by the yeast two-hybrid system. This effort identified SIKE, an evolutionarily conserved protein.
In mammalian overexpression systems, SIKE interacts with both IKKe and TBK1 (Figure 2A ). These interactions are mediated through their respective coiled-coil motifs ( Figure 2D ). We further demonstrated that SIKE is associated with TBK1 in untransfected cells. Upon viral infection or TLR3 engagement, SIKE is dissociated from the TBK1 complex as suggested by co-immunoprecipitation and gel filtration experiments ( Figure 2B and E). Since IKKe is undetectable under physiological conditions in most cell types (Shimada et al, 1999; Peters et al, 2000) , an endogenous interaction between SIKE and IKKe is not confirmed. It is possible that SIKE is associated with IKKe when IKKe is induced by certain stimuli.
In mammalian overexpression system, SIKE blocked the interactions of IKKe or TBK1 with TRIF, RIG-I and IRF-3 (Figures 4 and 6 ), signaling components required for TLR3-mediatd or virus-triggered IRF-3 activation (Yamamoto et al, 2002; Honda et al, 2003; Levy and Marie, 2004; Yoneyama et al, 2004) . In reporter gene assays, SIKE inhibited activation of ISRE and the IFN-b promoter mediated by IKKe, TBK1, TRIF and RIG-I, as well as triggered by poly(I:C) and VSV (Figures 3 and 5) , while knockdown of SIKE potentiated activation of ISRE and the IFN-b promoter triggered by poly(I:C) and VSV infection (Figure 7) . In VSV replication experiments, SIKE inhibited IKKe-and TBK1-mediated antiviral response, while knockdown of SIKE potentiated IKKeand TBK1-mediated antiviral state (Figure 8) .
SIKE does not disrupt the interactions of TRIF with TRAF6 and RIP ( Figure 4C ), components required for TLR3-mediated NF-kB activation (Hoebe et al, 2003; Sato et al, 2003; Han et al, 2004; Jiang et al, 2004; Meylan et al, 2004) . Consistently, SIKE does not inhibit NF-kB activation triggered by TNF, poly(I:C) and VSV. These results suggest that SIKE specifically inhibits IKKe-and TBK1-mediated ISRE activation pathways.
Since SIKE is associated with TBK1 under physiological conditions and dissociated with TBK1 upon TLR3 engagement or viral infection (Figure 2) , the simplest explanation for our observations is that SIKE functions as a physiological suppressor of IKKe and TBK1 by sequestering IKKe and TBK1 in inactive complexes. SIKE-mediated regulation of signaling is not caused by change of its protein level, because SIKE protein level was not significantly changed following TLR3 engagement or VSV infection ( Figure 2B and data not shown).
Although the experiments carried out in this study are not enough to offer a precise explanation on the regulatory mechanisms of SIKE in TLR3-mediated or virus-triggered signaling, some plausible scenarios can be envisioned. For example, upon TLR3 engagement or viral infection, the recruitment of TRIF to TLR3, or binding of RIG-I to dsRNA, may cause their conformational changes and thus provide a high-affinity binding site for IKKe/TBK1, causing dissociation of SIKE with IKKe/ TBK1 and subsequent activation of IKKe/TBK1. Alternatively, poly(I:C) engagement or viral infection may directly signal certain post-translational modifications or conformational changes of IKKe/TBK1 or SIKE, causing their dissociation and enabling the association of IKKe/TBK1 with TRIF or RIG-I. 5 ) were transfected with IRF-3 expression plasmid (2 mg) together with an empty control plasmid (2 mg), SIKE (2 mg), IKK-R (IKKe þ TBK1, each 0.5 mg) or IKK-R þ SIKE (0.5 mg of IKKe, 0.5 mg of TBK1 and 2 mg of SIKE). At 24 h after transfection, cells were infected with VSV (MOI 10) and supernatants were harvested at 0, 1, 3, 6, 9 and 12 h postinfection. Supernatants were analyzed for VSV production using standard plaque assays. Plaques were counted and titers calculated as PFU/ ml. (B) Knockdown of SIKE potentiates IKKe-and TBK1-mediated antiviral response. The experiments were carried out similarly as in (A), except that SIKE-RNAi plasmid was used to replace SIKE expression plasmid and the 293 cells were infected with VSV at 36 h after transfection.
Since type I IFNs play a vital role in innate antiviral response and provide potent regulatory interactions with the adaptive immune system for efficient virus elimination, they are tightly regulated at transcription level. Expression of type I IFNs is nearly undetectable in uninfected individuals, but rapidly induced to high concentrations following infection. The identification of a physiological suppressor of IKKe and TBK1 provides an explanation on the inability of these kinases to activate the IFN pathways under physiological conditions.
Materials and methods
Reagents
Mouse monoclonal and rabbit polyclonal antibodies against Flag and HA epitopes (Sigma, St Louis, MO), and rabbit polyclonal antibodies against NAK (TBK1) (eBioscience 14-6351) were purchased from the indicated manufacturers. VSV was provided by Dr Hong-Kui Deng. Mouse anti-SIKE and anti-IKKe antisera were raised against recombinant human SIKE(aa26-207) and IKKe proteins.
Yeast two-hybrid screening
To construct an IKKe bait vector, a cDNA fragment encoding fulllength human IKKe was inserted in-frame into the Gal4 DNAbinding domain vector pGBT (Clontech, Palo Alto, CA). A human B-cell cDNA library (ATCC, Manassas, VA) was screened following protocols recommended by Clontech.
Immunofluorescent staining
The 293 cells cultured on glass coverslips were plunged sequentially into methanol and acetone at À201C, each for 10 min. The cells were rehydrated in PBS, blocked with 1% bovine serum albumin in PBS for 15 min and stained with primary antibody in blocking buffer for 1 h at room temperature. The cells were rinsed with PBS and stained with Texas Red-conjugated Affinipure goat anti-mouse IgG (1:200 dilution) for 45 min at room temperature. The cells were then rinsed with PBS containing DAPI and mounted in Prolong Antifade (Molecular Probes). The cells were observed with a Leica DMR/ XA immunofluorescent microscope using a Â 100 plan objective.
Northern blot analysis
Human multiple tissue mRNA blot was purchased from Clontech. The blot was hybridized with 32 P-dCTP-labeled cDNA probe corresponding to human SIKE coding sequence. Hybridization was performed in the Rapid Hybridization Buffer (Clontech) under high stringency conditions.
Constructs
Mammalian expression plasmid pcDNA3-Flag-IKKe was provided by Dr Tom Maniatis. Mammalian expression plasmids for SIKE and its deletion mutants were constructed by PCR amplification of SIKE cDNA from human B-cell library and subsequently cloning into CMV promoter-based vectors containing an HA or Flag tag. HA-IKKe and its deletion mutants were constructed by PCR amplification of the IKKe cDNA from the pcDNA3-Flag-IKKe plasmid and subsequently cloning into a CMV promoter-based vector containing a tag. TBK1 deletion mutants were constructed by PCR amplification of the TBK1 cDNA from the PRK-Flag-TBK1 plasmid and subsequently cloning into a CMV promoter-based vector containing a tag. Mammalian expression plasmids for Flag-IKKa, Flag-TBK1, HA-TBK1, Flag-RIP, Flag-and HA-TRIF, Flag-TRAF6, Flag-IRF-3, Flag-RIG-1 and its deletion mutants were described previously (Hu et al, 1999; Bin et al, 2003; Han et al, 2004) . ISRE-luciferase reporter plasmid was purchased from Stratagene (West Cedar Creek, TX). NF-kB luciferase reporter plasmid was provided by Dr Gary Johnson. Human IFN-b promoter luciferase reporter plasmid was described previously (Han et al, 2004) .
Transfection and reporter gene assays
The 293 cells (B1 Â10 5 ) were seeded on 12-well dishes and transfected the following day by standard calcium phosphate precipitation. In the same experiment, where necessary, empty control plasmid was added to ensure that each transfection receives the same amount of total DNA. To normalize for transfection efficiency, 0.1 mg of pRL-TK Renilla luciferase reporter plasmid was added to each transfection. Approximately 16 h after transfection, luciferase assays were performed using a dual-specific luciferase assay kit (Promega, Madison, WI). Firefly luciferase activities were normalized based on Renilla luciferase activities. All reporter gene assays were repeated for at least three times. Data shown were average values7s.d. from one representative experiment.
Co-immunoprecipitation and Western blot analysis
For transient transfection and co-immunoprecipitation experiments, 293 cells (B1 Â10 6 ) were transfected for 24 h. The transfected cells were lysed in 1 ml of lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton, 1 mM EDTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). For each immunoprecipitation, 0.4 ml aliquot of lysate was incubated with 0.5 mg of the indicated antibody or control IgG and 25 ml of a 1:1 slurry of GammaBind G Plus-Sepharose (Amersham Biosciences) for 2 h. The Sepharose beads were washed three times with 1 ml of lysis buffer containing 500 mM NaCl. The precipitates were analyzed by Western blots as described (Huang et al, 2004) .
For endogenous co-immunoprecipitation experiments, cells (5 Â10 7 ) were treated with poly(I:C) (50 mg/ml) for 10 min or infected with VSV virus for 4 h or left untreated. Cells were then lysed in 5 ml lysis buffer and the lysate was incubated with 1 ml of the indicated antiserum or preimmune control serum. The subsequent procedures were carried out as described above.
Size-exclusion chromatography Cells (2 Â10
8 ) were lysed in 1.5 ml lysis buffer. The lysate was centrifuged for 1 h at 15 000 r.p.m. The supernatant was recovered and loaded onto a Superdex 200 gel filtration chromatography column pre-equilibrated with lysis buffer. The samples were eluted from the column in lysis buffer at a flow rate of 0.5 ml/min and collected in fractions of 1 ml. The fractions were precipitated with 10% trichloroacetic acid and analyzed by Western blots with antibodies against IKKe, TBK1 and SIKE, respectively.
RNAi experiments
Double-strand oligonucleotides corresponding to the target sequences were cloned into the pSuper.Retro RNAi plasmid (Oligoengine Inc.). The following sequences were targeted for human SIKE cDNA: (1) GAGGATGCATCCGATATGA; (2) AGCTCACCAGTCT CACTCT; (3) GGAACTTCGAGAATTATTG; (4) GGACATGTCCAAA TACAAA; and (5) ATACAAACCTCACATTCTG.
RT-PCR
Total RNA was isolated from 293 cells using Trizol reagent (Tianwei, China) and subjected to RT-PCR analysis to measure expression of IFN-b, Rantes and GAPDH according to the manufacturer's instructions. Gene-specific primer sequences were as follows: IFN-b, 5 0 -CAGCAATTTTCAGTGTCAGAAGCT-3 0 and 5 0 -TCATCCTGTCCTTGA GGCAGTAT-3 0 ; Rantes, 5 0 -ATGAAGGTCTCCGCGGCACGCCT-3 0 and 5 0 -CTAGCTCATCTCCAAAGAGTTG-3 0 ; and GAPDH, 5 0 -AAAATCAAGT GGGGCGATGCT-3 0 and 5 0 -GGGCAGAGATGATGACCCTTT-3 0 .
VSV plaque assay
The 293 cells (1 Â10
5
) were transfected with the indicated plasmids for 24 or 36 h prior to VSV infection (MOI of 10.0). At 1 h after infection, cells were washed with PBS for three times and then medium was added. The supernatants were harvested at 0, 1, 3, 6, 9 and 12 h after washing. The supernatants were diluted 1:10 6 and then used to infect confluent BHK21 cells cultured on 24-well plates. At 1 h postinfection, supernatant was removed and 3% methylcellulose was overplayed. At 3 days postinfection, overlay was removed, cells were fixed with 4% formaldehyde for 1 h and stained with 0.2% Crystal violet in 20% methanol. Plaques were counted, averaged and multiplied by the dilution factor to determine viral titer as PFU/ml.
